AVACC 10
Live / Registered — Registered (as of 28 Nov 2023)
What this means for you
Registered since 28 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79346219
- Registration number
- 7226960
- Mark type
- Stylized text
- Filed
- 17 May 2022
- Published for opposition
- 12 Sept 2023
- Registered
- 28 Nov 2023
- Attorney of record
- Jeffrey H. Greger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases and allergic diseases, as well as pharmaceutical products and preparations against cancer; vaccines; and medicines for human use for prevention, treatment and immune therapy and combinations of prevention, treatment and immune therapy of infectious diseases, allergic diseases and cancer; bacterial and viral vaccines, synthetic, recombinant, peptide, protein, RNA-, DNA- and therapeutic vaccines; all the aforementioned products not for the ocular, periocular and vision field; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugates
- Class 010 — Medical apparatus: Apparatus and containers for the administration of vaccines and medicines, namely cups for dispensing medicine, injection needles for the administration of vaccines and medicines, injection instruments without needles for the administration of vaccines and medicines, nose sprayers for medical purposes and spray syringes for medical purposes; all the aforementioned products not for the ocular, periocular and vision field; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibodies; all the aforementioned products not in relation to pharmaceutical medicines for cancer therapies consisting of and/or comprising antibody drug conjugates
Owner
- Intravacc B.V., NL
- Intravacc B.V., NL
- Intravacc B.V., NL
Prosecution history
- 21 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Mar 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 29 Feb 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 29 Feb 2024 — FINAL DISPOSITION PROCESSED
- 28 Feb 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 28 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 12 Sept 2023 — NOTIFICATION PROCESSED BY IB
- 12 Sept 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Sept 2023 — PUBLISHED FOR OPPOSITION
- 23 Aug 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Aug 2023 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 23 Aug 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED